{"filing":{"accession_number":"0001468091-26-000032","cik":"0001468091","ticker":"VEON","company_name":"VEON Ltd.","form":"6-K","filing_date":"2026-07-31","report_date":"2026-06-30","primary_document":"form6-k2q2026tradingupdate.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1468091/000146809126000032/form6-k2q2026tradingupdate.htm"},"events":[{"id":22853,"run_id":20686,"accession_number":"0001468091-26-000032","anchor_item_number":"EX-99.1","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"VEON disclosed financial results for the second quarter and first half of 2026, reporting total revenue of USD 1,271 million (+17.0% YoY) and EBITDA of USD 552 million (+6.2% YoY), with diluted EPS of USD 1.69. The company raised its full-year 2026 guidance, projecting revenue growth of 15%–18% YoY and EBITDA growth of 9%–12% YoY.","company_name":"VEON Ltd.","ticker":"VEON","filing_date":"2026-07-31","form":"6-K","submitted_at":null,"items":[{"id":22927,"accession_number":"0001468091-26-000032","item_number":"EX-99.1","item_title":"veon2q26earningsrelease.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a formal earnings release disclosing VEON's financial results for the second quarter and first half of 2026. The document presents total revenue of USD 1,271 million (+17.0% YoY), EBITDA of USD 552 million (+6.2% YoY), and diluted EPS of USD 1.69, along with raised full-year 2026 guidance (revenue growth 15%–18% YoY, EBITDA growth 9%–12% YoY). The release includes detailed operational metrics, segment performance, and forward guidance, which are material to investors' assessment of the company's financial condition and performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-02T02:34:21.824962+00:00","company_name":"","ticker":null,"filing_date":""},{"id":22928,"accession_number":"0001468091-26-000032","item_number":"EX-99.2","item_title":"veon2q26presentation2.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a 2Q26 results presentation dated July 31, 2026, disclosing VEON's second-quarter and half-year 2026 financial results. The document presents key financial metrics including revenue (USD 1,271 million, +17.0% YoY), EBITDA (USD 552 million, +6.2% YoY), and earnings per ADS (USD 1.69), along with forward guidance raising 2026 revenue and EBITDA outlook. This is a discrete earnings announcement, not a periodic financial report filing.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-02T02:34:21.824962+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22927,"accession_number":"0001468091-26-000032","item_number":"EX-99.1","item_title":"veon2q26earningsrelease.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a formal earnings release disclosing VEON's financial results for the second quarter and first half of 2026. The document presents total revenue of USD 1,271 million (+17.0% YoY), EBITDA of USD 552 million (+6.2% YoY), and diluted EPS of USD 1.69, along with raised full-year 2026 guidance (revenue growth 15%–18% YoY, EBITDA growth 9%–12% YoY). The release includes detailed operational metrics, segment performance, and forward guidance, which are material to investors' assessment of the company's financial condition and performance.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-02T02:34:21.824962+00:00","company_name":"VEON Ltd.","ticker":"VEON","filing_date":"2026-07-31"},{"id":22928,"accession_number":"0001468091-26-000032","item_number":"EX-99.2","item_title":"veon2q26presentation2.htm","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a 2Q26 results presentation dated July 31, 2026, disclosing VEON's second-quarter and half-year 2026 financial results. The document presents key financial metrics including revenue (USD 1,271 million, +17.0% YoY), EBITDA (USD 552 million, +6.2% YoY), and earnings per ADS (USD 1.69), along with forward guidance raising 2026 revenue and EBITDA outlook. This is a discrete earnings announcement, not a periodic financial report filing.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-02T02:34:21.824962+00:00","company_name":"VEON Ltd.","ticker":"VEON","filing_date":"2026-07-31"},{"id":22929,"accession_number":"0001468091-26-000032","item_number":"EX-99.3","item_title":"factbook2q26.htm","event_type":"periodic_quarterly","event_domain":"periodic","is_material":false,"confidence":0.95,"reasoning":"This exhibit is a financial factbook containing consolidated and segment-level quarterly financial statements and operational metrics for VEON Ltd. for 2Q26 (second quarter 2026) and prior periods. It presents revenue, EBITDA, EBIT, capex, and detailed telecom/digital metrics across Pakistan, Ukraine, Kazakhstan, and other markets. This is a periodic quarterly financial report itself, not a discrete event or earnings press release announcement.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-02T02:34:21.824962+00:00","company_name":"VEON Ltd.","ticker":"VEON","filing_date":"2026-07-31"}]}